Headline News

 

Dana-Farber Cancer Institute and Deerfield Collaborate to Create the Centre for Protein Degradation

Posted on November 13, 2018

SGS Expands Elemental Impurity Testing Services at its Laboratory in Chennai, India

Posted on November 13, 2018

Lupin’s Budesonide Inhalation Suspension, 0.5 mg/2 mL Receives FDA approval

Posted on November 13, 2018

Second Catalent Clinical Supply Facility In To Be Opened China

Posted on November 13, 2018

Abzena Invests 20m$ Into Expansion Of Integrated Biotherapeutics Offering (Biologics Drug Substance And ADC) And Makes Key Executive Appointment

Posted on November 12, 2018

First 2,000L Single-Use Bioreactor (SUB) Batch from Singapore for TRACON Pharmaceuticals Released by Lonza

Posted on November 12, 2018

GE Healthcare starts to manufacture single-use consumables in China through collaboration with Wego

Posted on November 07, 2018

AbbVie Announces VENCLYXTO® (venetoclax) Plus Rituximab Receives European Commission Approval

Posted on November 06, 2018

Sandoz Decides Not To Pursue US Biosimilar Rituximab; Will Focus On Robust Biosimilar Portfolio For Unmet Access And Sustainability Needs

Posted on November 06, 2018

AcelRx announces DSUVIA™ Receives FDA approval

Posted on November 06, 2018

Construction of New Research, Development and Manufacturing Facilities for Drugs Using Innovative Modalities/Technologies Including Antibodies and Cell Therapies Announced by Astellas

Posted on November 06, 2018

Pfizer’s LORBRENA® (LORLATINIB) For Previously-Treated ALK-Positive Metastatic NSCLC receives U.S. FDA Approval

Posted on November 05, 2018

CE Mark For Use In Europe Secured by ABBOTT′S FREESTYLE® LIBRE 2, With Optional Real-Time Alarms

Posted on November 05, 2018

In Shijiazhuang, WuXi Biologics Commenced Construction of 48,000L Biologics Commercial Manufacturing Center

Posted on November 01, 2018

Dr. Reddy’s Laboratories Announces The Launch Of Atomoxetine Capsules, USP in the U.S. Market

Posted on October 31, 2018